ChemoCentryx posts 4Q profit

MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Friday reported fourth-quarter net income of $39.7 million, after reporting a loss in the same period a year earlier.

The Mountain View, California-based company said it had profit of 80 cents per share.

The biopharmaceutical company posted revenue of $56.3 million in the period.

For the year, the company reported net income of $17.9 million, or 36 cents per share, swinging to a profit in the period. Revenue was reported as $82.5 million.

ChemoCentryx shares have risen 83 percent since the beginning of the year. The stock has risen 63 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CCXI at https://www.zacks.com/ap/CCXI